InsiderTrades.com logo

ALP Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $254,815.49
Insider Selling (Last 12 Months): $0.00

Portage Biotech Insider Trading History Chart

This chart shows the insider buying and selling history at Portage Biotech by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Portage Biotech Share Price & Price History

Current Price: $2.98
Price Change: ▼ Price Decrease of -0.04 (-1.32%)
As of 10/26/2026 04:00 PM ET

This chart shows the closing price history over time for ALP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Portage Biotech Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/7/2026Fiorenzo VillaniInsiderBuy5,150$3.80$19,570.0054,036View SEC Filing Icon  
9/22/2026Fiorenzo VillaniInsiderBuy10,000$4.40$44,000.0048,886View SEC Filing Icon  
9/16/2026Fiorenzo VillaniInsiderBuy4,265$4.05$17,273.2538,886View SEC Filing Icon  
9/15/2026Fiorenzo VillaniInsiderBuy10,382$4.07$42,254.7434,601View SEC Filing Icon  
9/15/2026Fiorenzo VillaniInsiderBuy7,900$4.15$32,785.0011,917View SEC Filing Icon  
9/14/2026Fiorenzo VillaniInsiderBuy2,000$4.16$8,320.0024,219View SEC Filing Icon  
9/9/2026Brittany KaiserCEOBuy9,350$5.35$50,022.5016,766View SEC Filing Icon  
9/9/2026Fiorenzo VillaniInsiderBuy7,000$5.07$35,490.0022,219View SEC Filing Icon  
9/9/2026Wesley Allen LevittCFOBuy1,000$5.10$5,100.001,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Portage Biotech (NASDAQ:ALP)

13.36% of Portage Biotech stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Portage Biotech logo
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.
Read More on Portage Biotech

Today's Range

Now: $2.98
Low: $2.86
High: $3.18

50 Day Range

MA: $5.41
Low: $2.97
High: $8.95

52 Week Range

Now: $2.98
Low: $2.78
High: $280.13

Volume

27,334 shs

Average Volume

180,562 shs

Market Capitalization

$4.62 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.63

Who are the company insiders with the largest holdings of Portage Biotech?

Portage Biotech's top insider investors include:
  1. Fiorenzo Villani (Insider)
  2. Brittany Kaiser (CEO)
  3. Wesley Allen Levitt (CFO)
Learn More about top insider investors at Portage Biotech.

Portage Biotech Active Insiders

Brittany Kaiser
Brittany Kaiser
CEO
1 recent trades
Fiorenzo Villani
Fiorenzo Villani (Age 55)
Insider
7 recent trades